Glaukos reports positive Phase 4 topline results for iDose TR
Glaukos said its Phase 4 prospective, randomized, controlled trial evaluating iDose TR with cataract surgery delivered positive topline results.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.